LINC00662 facilitates osteosarcoma progression via sponging miR-103a-3p and regulating SIK2 expression

被引:11
作者
Huang, Jianghu [1 ,2 ]
Lin, Feiyue [1 ,2 ]
Xu, Chuncai [1 ,2 ]
Xu, Yang [1 ,2 ]
机构
[1] Fujian Med Univ, Shengli Clin Med Coll, Fuzhou 350001, Fujian, Peoples R China
[2] Fujian Med Univ, Fujian Prov Hosp, Dept Orthoped, Fuzhou 350001, Fujian, Peoples R China
关键词
LINC00662; miR-103a-3p; osteosarcoma; SIK2; CANCER CELLS; PROLIFERATION;
D O I
10.1002/term.3242
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Long non-coding RNA (lncRNA) involvement in regulating assorted cancers has been determined. Long intergenic non-protein coding RNA 662 (LINC00662) has been studied in gastric cancer. However, its function was not elucidated in osteosarcoma (OS). Thus, we aimed to discover LINC00662 function and the corresponding mechanism in OS. In this study, we found that LINC00662 displayed high expression in OS cells. LINC00662 down-regulation negatively affected OS cell malignant behaviors and tumor growth. Subsequently, miR-103a-3p was proven to bind with LINC00662 and overexpression of miR-103a-3p inhibited OS cell proliferation, migration and invasion. Then, SIK2, the downstream of miR-103a-3p, was up-regulated in OS cells and positively regulated by LINC00662. In addition, knockdown of SIK2 exerted inhibitory effects on proliferative, migratory and invaded capacities of OS cells. More interestingly, miR-103a-3p depletion or SIK2 overexpression restored the impacts of down-regulated LINC00662 on OS cells. In conclusion, LINC00662 could facilitate OS progression via miR-103a-3p/SIK2 axis.
引用
收藏
页码:1082 / 1091
页数:10
相关论文
共 26 条
[1]   HUMAN INTERFERON - MASS-PRODUCTION IN A NEWLY ESTABLISHED CELL LINE, MG-63 [J].
BILLIAU, A ;
EDY, VG ;
HEREMANS, H ;
VANDAMME, J ;
DESMYTER, J ;
GEORGIADES, JA ;
DESOMER, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (01) :11-15
[2]   Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy [J].
Chen, Fangyu ;
Chen, Liuwei ;
Qin, Qin ;
Sun, Xinchen .
FRONTIERS IN ONCOLOGY, 2019, 9
[3]   The vicissitudes of gene therapy [J].
Evans, C. H. .
BONE & JOINT RESEARCH, 2019, 8 (10) :469-471
[4]   Applications of CRISPR for musculoskeletal research [J].
Fitzgerald, J. .
BONE & JOINT RESEARCH, 2020, 9 (07) :351-359
[5]  
Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI DOI 10.1007/978-1-4757-1647-45
[6]  
HARRIS SA, 1995, J BONE MINER RES, V10, P178
[7]  
Jimmy Rincy, 2017, JBI Database System Rev Implement Rep, V15, P2113, DOI 10.11124/JBISRIR-2016-003105
[8]   Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a [J].
Li, N. ;
Zhang, L-Y ;
Qiao, Y-H ;
Song, R-J .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (09) :3688-3698
[9]   lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR-125a-5p [J].
Liu, Yungyong ;
Li, Mengdan ;
Yu, Huihui ;
Piao, Haozhe .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 45 (02) :497-509
[10]   LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway [J].
Liu, Zhen ;
Yao, Yangyang ;
Huang, Shanshan ;
Li, Li ;
Jiang, Bailing ;
Guo, Hui ;
Lei, Wan ;
Xiong, Jianping ;
Deng, Jun .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (03) :843-849